High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment

Leukemia Research

Volumn 38, Issue 1, 2014, Pages 71-75

  Cogle, Christopher R ^a   Iannacone, Michelle R ^b   Yu, Daohai ^b,d   Cole, Ashley L ^b   Imanirad, Iman ^a   Yan, Lulu ^b   MacKinnon, Jill A ^c   List, Alan F ^b   Rollison, Dana E ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Myelodysplastic syndromes

Indexed keywords

ACCURACY; AGE DISTRIBUTION; AGED; ALGORITHM; ARTICLE; CANCER REGISTRY; ELECTRONIC MEDICAL RECORD; ELECTRONIC PATHOLOGY; FEMALE; HUMAN; INCIDENCE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; UNITED STATES;

EID: 84890559862     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.10.023     Document Type: Article

References (10)

1. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
2. Ma X., Does M., Raza A., Mayne S.T. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007, 109:1536-1542.
3. De Roos A.J., Deeg H.J., Davis S. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers. Cancer Causes Control 2007, 18:1199-1208.
4. Rollison D.E., Howlader N., Smith M.T., Strom S.S., Merritt W.D., Ries L.A., et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008, 112:45-52.
5. Cogle C.R., Craig B.M., Rollison D.E., List A.F. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. Blood 2011, 117:7121-7125.
6. Goldberg S.L., Chen E., Corral M., Guo A., Mody-Patel N., Pecora A.L., et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol 2010, 28:2847-2852.
7. Craig B.M., Rollison D.E., List A.F., Cogle C.R. Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes. Leukemia Res 2011, 35:1453-1456.
8. NCCN Guidelines: myelodysplastic syndromes NCCN clinical practice guidelines in oncology 2010, Version 1.2011.
9. De Roos A.J., Deeg H.J., Onstad L., Kopecky K.J., Bowles E.J., Yong M., et al. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006. Am J Hematol 2010.
10. Craig B.M., Rollison D.E., List A.F., Cogle C.R. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev 2012, 21:474-481.